This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial, American Heart Journal, May 2006, Elsevier,
DOI: 10.1016/j.ahj.2006.02.028.
You can read the full text:
The following have contributed to this page
Psychology of Violence
In some countries and states, it is a criminal offense to engage in "controlling or coercive" behavior towards an intimate partner that causes them to fear future violence or that affects their dai...
Journal of the Royal Society of Medicine
This is an explanation of why the system is illegal and a demand for change.
Journal of Paramedic Practice
With around 3,000 known species of human pathogens it is likely that winter pressures may be far more complex than anticipated. The processes surrounding pathogen interference will contribute to th...
